Perceived self-efficacy and pain control: Opioid and nonopioid mechanisms.

Bandura, Albert; O’Leary, Ann; Taylor, C. Barr; Gauthier, Janel; Gossard, Denis

doi:10.1037/0022-3514.53.3.563

Cited by 314 publications

(212 citation statements)

References 18 publications

Supporting

Mentioning

174

Contrasting

Unclassified

Order By: Relevance

“…In prospective studies, SE predicts outcomes for post-surgical pain rehabilitation [144,155]. Similar to perceived control, SE may contribute to pain control through the perception of the reduced challenge of pain or effects on neurotransmitter mechanisms associated with increased pain tolerance such as endogenous opioid release [57].…”

Section: Interventional Pain Medicine and Pain Beliefsmentioning

confidence: 99%

“…Psychological therapies with established efficacy for the treatment of chronic pain also interact with the cortical mechanisms of pain perception [47] and have a direct impact on brain processing of pain. For example, brief training in simple techniques for psychological control of pain, such as imagery and distraction, enhance endogeneous opioid release during an experimental pain task [57]. Manipulation of attention and the use of distraction to control pain during noxious stimulation are associated with painevoked neuromodulation in the pain matrix [6,58,59].…”

Section: Early Understanding Of Basic Pain Mechanisms and The Biomedimentioning

confidence: 99%

See 1 more Smart Citation

Interventional pain medicine: retreat from the biopsychosocial model of pain

Roth

Geisser

Williams

2011

Behav. Med. Pract. Policy Res.

View full text Add to dashboard Cite

The field of pain medicine has shifted from multidisciplinary rehabilitation to procedure-focused interventional pain medicine (IPM). Considerable controversy exists regarding the efficacy of IPM and its more narrow focus on nociception as an exclusive target of pain treatment. This topical review aims to examine pain research and treatment outcome studies that support a biopsychosocial model of pain, and to critique the clinical practice of IPM given its departure from the premises of a biopsychosocial model. A modern definition of pain and findings from clinical and basic science studies indicate that pain-related psychological factors are integral to pain perception. The clinical viability of IPM is challenged based upon its biomedical view of peripheral nociception as a primary source of pain and the potential of this viewpoint to foster maladaptive pain attributions and discourage the use of pain coping strategies among chronic pain patients. IPM should adopt a biopsychosocial perspective on pain and operate within a framework of multidisciplinary pain rehabilitation to improve its effectiveness. KEYWORDS

show abstract

Section: Interventional Pain Medicine and Pain Beliefsmentioning

confidence: 99%

Section: Early Understanding Of Basic Pain Mechanisms and The Biomedimentioning

confidence: 99%

Interventional pain medicine: retreat from the biopsychosocial model of pain

Roth

Geisser

Williams

2011

Behav. Med. Pract. Policy Res.

View full text Add to dashboard Cite

show abstract

“…In studies of pain control, participants who are given some measure of control over a painful stimulus tend to report lower pain ratings than when they receive the same pain relief delivered by someone else [48]. Similarly, patients trained in cognitive (vs. pharmaceutical) pain management strategies are typically better able to tolerate and alleviate pain [49].…”

Section: Perceived Controlmentioning

confidence: 99%

Adjustable Green Defaults Can Help Make Smart Homes More Sustainable

Sintov

Schultz

2017

Sustainability

View full text Add to dashboard Cite

Smart home technologies offer exciting opportunities to promote more efficient uses of energy. For instance, programmable thermostats, centralized lighting controls, and rooftop solar panels all have potential for energy conservation and efficiency. However, these technologies alone will not guarantee energy savings. Whereas previous research on smart homes has focused on the technologies themselves, relatively little work has addressed the factors that shape the human-technology interface. In this review paper, we argue that in order to ensure any savings, smart home technologies must first be adopted by end-users, and once adopted, they must be used in ways that promote energy efficiency. We focus on three areas of behavioral research with implications for smart home technologies: (1) defaults; (2) perceived adjustability or control; and (3) trust in automation. Linking these areas, we propose a new concept for improving the efficiency gains of smart homes. First, although smart device controls can help save energy, considerably larger energy efficiency gains can be realized through smart automation. But importantly, the default settings of systems should be "green", to maximize energy savings. Second, many people have concerns around relinquishing decision-making to technologies, which can reduce the likelihood of adoption. People want to be, or at least to feel, in control of their homes, even if they do not adjust settings post-installation. Further, consumer trust in technologies encourages adoption in the first place; trust also impacts consumer interactions with installed devices and can impact default acceptance. Combining these concepts, we recommend that smart home technologies build consumer trust and come pre-programmed with adjustable green defaults, which permit consumers to change initial green settings.

show abstract

“…With the addition of relaxation techniques, he gained significant control over the headache pain and decreased his medication use. Bandura and colleagues 8 suggest that perceived self-efficacy in controlling pain using coping skills is directly related to a subjects' ability to tolerate pain. The ability to control pain was partially abolished by naloxone, an opiate antagonist.…”

Section: Commentsmentioning

confidence: 99%

Codeine Self‐medication in a Headache Patient

Eng

Lachenmeyer

1996

Headache

View full text Add to dashboard Cite

Self-medicating behavior for the treatment of headaches is a widespread phenomenon with costly and hazardous consequences. The case presented illustrates the ramifications of such behavior and suggests an integrated approach to the management of headaches. Biological mechanisms for the aggravation of headaches by self-medication are discussed and integrated with psychological observations. The existing epidemiologic studies of self-medication are reviewed and reveal a need for further studies, particularly in the United States. Key words: codeine, self-medication (Headache 1996;36:452-455) The extent of self-medicating behavior for chronic headaches has had minimal attention in the medical literature. Yet, it is a widespread phenomenon in this common disorder. Limitations to the systematic study of self-medication in headaches include inconsistent patient contact with the medical community and inaccurate or underreporting of drug use. The latter is particularly common in instances of narcotic abuse. In the former case, it is quite clear that many individuals can bypass medical attention and obtain treatment at their local pharmacy, where a host of over-the-counter (OTC) medications advertise prompt headache relief. CASE HISTORYThe following is a case report of a chronic headache patient with a 25-year history of acetaminophen (Tylenol ® ) and codeine self-medication. The case illustrates the complications resulting from self-medicating behaviors. It also affords an opportunity to study the role of psychological treatments and how such treatments can be integrated into the management of chronic headaches.A 54-year-old patient was referred to a drug treatment program after he was caught by his pharmacist forging a prescription for Tylenol ® No. 4 with codeine. The patient stated that he "pops 6 to 15 pills a day" in order to medicate severe headaches which began when he was in his 20s. Initially, the headaches responded to acetaminophen alone but over the past 10 years, he began to abuse acetaminophen with codeine in gradually increasing doses. He obtained it by using forged prescriptions or from the "black market" to medicate the pain. He often took the pills at the slightest suggestion of a headache and sometimes even when he was asymptomatic in order to avert headaches, particularly when he had an important matter to take care of at work.The patient reported obtaining medical attention for his headaches many times in the past 10 years. Multiple evaluations, including physical examinations, neurological evaluations, complete blood screening, ECG, and several CT scans of the head, were unremarkable. The headaches were described as "stinging" and localized in the forehead. They might occur at any time of the day, and they often woke him at night. The headaches were not preceded by any aura or accompanied by visual, gastrointestinal, or neurological symptoms. His only other health problems were hypertension for 5 years treated with clonidine 0.1 mg orally tid for the past 5 years, a peptic ulcer which had been q...

show abstract

Perceived self-efficacy and pain control: Opioid and nonopioid mechanisms.

Cited by 314 publications

References 18 publications

Interventional pain medicine: retreat from the biopsychosocial model of pain

Interventional pain medicine: retreat from the biopsychosocial model of pain

Adjustable Green Defaults Can Help Make Smart Homes More Sustainable

Codeine Self‐medication in a Headache Patient

Contact Info

Product

Resources

About